文献速递帕金森病与运动障碍认知障碍与痴呆

基于人群的方法探讨路易体病脑先起病与体先起病发病机制

A Population-Based Approach to the Argument on Brain-First and Body-First Pathogenesis of Lewy Body Disease.
PubMed 文献 · Ann Neurol · 2024-06-11

利用罗切斯特流行病学项目建立临床诊断路易体病(LBD)的人群队列,采用两种体先起病定义比较脑先与体先患者的临床进展。结果:脑先患者更易诊断为帕金森病(RR=1.43,p=0.003),体先患者更易诊断为路易体痴呆(RR=3.15,p<0.001);扩展定义下两组LBD诊断无差异(帕金森病RR=1.03,p=0.10;路易体痴呆RR=0.88,p=0.58)。结论不支持当前定义的脑先/体先二分法。

要点

  • 脑先患者更易诊断为帕金森病(RR=1.43,p=0.003),体先患者更易诊断为路易体痴呆(RR=3.15,p<0.001)。
  • 扩展定义下脑先与体先患者的LBD诊断无差异(帕金森病RR=1.03,p=0.10;路易体痴呆RR=0.88,p=0.58)。
  • 两种定义下脑先/体先与帕金森病痴呆均无关联(原始定义p=0.09,扩展定义p=0.97),运动症状无显著差异。

核心结论

  • 研究结果不支持当前提出的定义对体先和脑先路易体病的二分法分类。
  • 导致帕金森病和路易体痴呆的生物学暴露不太可能汇聚于自上而下或自下而上的突触核蛋白病理二元分类。

研究设计与样本

  • 利用罗切斯特流行病学项目建立基于人群的临床诊断路易体病队列。
  • 采用两种定义区分脑先与体先路易体病:一是先前假设的体先表现,即快速眼动睡眠行为障碍在运动症状之前起病;二是扩展定义,即患者至少有2个前驱症状(便秘、勃起功能障碍、快速眼动睡眠行为障碍、嗅觉丧失或神经源性膀胱)。

主要发现

  • 脑先患者更可能诊断为帕金森病(RR=1.43,p=0.003),体先患者更可能诊断为路易体痴呆(RR=3.15,p<0.001)。
  • 扩展定义下,脑先与体先患者的LBD诊断无差异(帕金森病:RR=1.03,p=0.10;路易体痴呆:RR=0.88,p=0.58)。
  • 两种定义下,脑先或体先表现与帕金森病痴呆之间无模式(原始定义:p=0.09;扩展定义:p=0.97)。
  • 脑先与体先患者之间运动症状无显著差异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore the clinical progression of the brain-/body-first categories within Lewy body disease (LBD): Parkinson's disease (PD), dementia with Lewy bodies (DLB), and PD dementia. METHODS: We used of the Rochester Epidemiology Project to establish a population-based cohort of clinically diagnosed LBD. We used two definitions for differentiating between brain- and body-first LBD: a previously hypothesized body-first presentation in patients with rapid eye movement sleep behavior onset before motor symptoms onset; and an expanded definition of body-first LBD when a patient had at least 2 premotor symptoms between constipation, erectile dysfunction, rapid eye movement sleep behavior, anosmia, or neurogenic bladder. RESULTS: Brain-first patients were more likely to be diagnosed with PD (RR = 1.43, p = 0.003), whereas body-first patients were more likely to be diagnosed with DLB (RR = 3.15, p < 0.001). Under the expanded definition, there was no difference in LBD diagnosis between brain-first and body-first patients (PD: RR = 1.03, p = 0.10; DLB: RR = 0.88, p = 0.58) There were no patterns between brain- or body-first presentation, PD dementia under either definition (original: p = 0.09, expanded: p = 0.97), and no significant difference in motor symptoms between brain-first and body-first. INTERPRETATION: Our findings do not support the dichotomous classification of body-first and brain-first LBD with the currently proposed definition. Biological exposures resulting in PD and DLB are unlikely to converge on a binary classification of top-down or bottom-up synuclein pathology. ANN NEUROL 2024;96:551-559.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Camerucci E, Mullan AF, Turcano P, et al. A Population-Based Approach to the Argument on Brain-First and Body-First Pathogenesis of Lewy Body Disease. Ann Neurol. 2024. PMID: 38860478. doi:10.1002/ana.27006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。